Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)

Experience with tocilizumab in patients with rheumatoid arthritis (according to the data of the LORNET multicenter trial)

Objective: to estimate quality of life changes in patients with rheumatoid arthritis (RA) while adding tocilizumab (TCZ) to therapy with disease-modifying antirheumatic drugs (DMARDs) and to study the efficiency and safety of the therapy in RA patients with an inadequate response to previous DMARD t...

Full description

Saved in:

Bibliographic Details
Main Authors:	E Yu Panasyuk, V N Amirdzhanova, Anastasia Sergeyevna Avdeyeva, E L Luchikhina, E N Aleksandrova, A A Novikov, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2013-04-01
Series:	Научно-практическая ревматология
Subjects:	das28 sdai rheumatoid arthritis tocilizumab quality of life remission
Online Access:	https://rsp.mediar-press.net/rsp/article/view/773
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the clinical efficiency of tocilizumab therapy, by using DAS 28, SDAI, CDAI indices and new 2011 EULAR/ACR remission criteria in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-04-01)

Evaluation of the clinical efficiency of tocilizumab versus rituximab therapy in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-08-01)

ASSESSMENT OF RHEUMATOID ARTHRITIS ACTIVITY DURING PREGNANCY AND POSTPARTUM
by: E. V. Matyanova, et al.
Published: (2015-04-01)

IMPACT OF TOCILIZUMAB THERAPY ON STRUCTURAL JOINT DAMAGE PROGRESSION IN RHEUMATOID ARTHRITIS
by: Anastasia Sergeevna Avdeeva, et al.
Published: (2012-10-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
by: Anna Olegovna Pchelintseva, et al.
Published: (2014-02-01)

Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2012-06-01)

Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III
by: E. V. Akatova, et al.
Published: (2024-12-01)

SERUM FETUIN-A LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Papichev, et al.
Published: (2019-09-01)

Regular use of non-steroidal anti-inflammatory drugs can effectively control pain and global health in patients with moderate activity of rheumatoid arthritis
by: A. E. Karateev, et al.
Published: (2021-04-01)

Serum leptin level in rheumatoid arthritis and its relationship with disease activity
by: Zena M Al-Youzbaky, et al.
Published: (2023-02-01)

LEVELS OF ANGIOGENESIS-REGULATORY CHEMOKINES IN THE SYNOVIAL FLUID OF PATIENTS WITH RHEUMATOID ARTHRITIS
by: D. A. Zhebrun, et al.
Published: (2015-03-01)

Caracterização molecular de populações de Meloidogyne enterolobii e M. konaensis no estado do Ceará, Brasil
by: Francisco Jorge Carlos de Souza Junior, et al.
Published: (2024-12-01)

IMPACT OF PREGNANCY ON THE ACTIVITY OF RHEUMATOID ARTHRITIS AND ITS THERAPY ACCORDING TO PROSPECTIVE FOLLOW-UP DATA
by: E. V. Matyanova, et al.
Published: (2015-09-01)

The Role of IL-37 as an Anti-Inflammatory Biomarker in some Iraqi Rheumatoid Arthritis Patients and Its Correlation with DAS28
by: Sattar Brissm Hassan, et al.
Published: (2022-11-01)

Impact of vitamin D supplementation on disease activity and pain management in rheumatoid arthritis: a randomized double-blinded controlled study
by: Mjellma Rexhepi, et al.
Published: (2025-07-01)

Metabolic aspects of clinical remission prediction from baseline blood gene expression in patients with rheumatoid arthritis treated with methotrexate
by: E. V. Chetina, et al.
Published: (2019-05-01)

Impact of tocilizumab therapy on fatigue in patients with rheumatoid arthritis
by: Anna Sergeyevna Starkova, et al.
Published: (2012-06-01)

A Cross-Sectional Study of Depression in Rheumatoid Arthritis Patients at a Tertiary Care Center
by: Hansraj Parmar, et al.
Published: (2025-05-01)

RAPID EFFECT OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
by: E Yu Panasyuk, et al.
Published: (2011-08-01)

Efficacy of Ozoralizumab vs. Golimumab for Rheumatoid Arthritis: A Systematic Review
by: Nathania Elma Fithriyah, et al.
Published: (2025-07-01)

Analysis of peripheral blood parameters for the diagnosis of inflammatory activity in rheumatoid arthritis
by: V. Muravyov, et al.
Published: (2022-03-01)

CHANGES IN CALPROTECTIN LEVEL, ITS RELATIONSHIP TO THE CLINICAL AND LABORATORY PARAMETERS OF DISEASE ACTIVITY AND SIGNIFICANCE FOR PREDICTING THE THERAPEUTIC RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
by: A. O. Pchelintseva, et al.
Published: (2015-09-01)

Comparison of clinical manifestations of rheumatoid arthritis in patients with moderate or high disease activity depending on the presence or absence of symptoms of neuropathic pain
by: E. Yu. Polishchuk, et al.
Published: (2021-12-01)

FUNCTIONAL ABILITY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOCILIZUMAB THERAPY
by: Anna Sergeyevna Starkova, et al.
Published: (2014-02-01)

Correlation Analysis of Coagulation and Platelet Parameters with Clinical Outcomes in Rheumatoid Arthritis Patients and the Interventional Effect of Jianpi Huashi Tongluo Formula - Xinfeng Capsule: A Post Hoc Analysis Based on an Randomized Controlled Trial
by: Wang F, et al.
Published: (2025-04-01)

Factors associated with rs1801394 of the methionine synthase reductase gene polymorphism in patients with rheumatoid arthritis
by: M. Yu. Krylov, et al.
Published: (2021-06-01)

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
by: E. S. Zhugrova, et al.
Published: (2014-07-01)

EVALUATION OF ULTRASOUND REMISSION CRITERIA IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-12-01)

High prevalence of methotrexate intolerance in rheumatoid arthritis patients: a cross-sectional study
by: Harjit Singh Nalwa, et al.
Published: (2025-07-01)

THE INFLUENCE OF COMPLEX THERAPY ON THE INFLAMMATORY MARKERS OF PATIENTS WITH SECONDARY OSTEOARTHRITIS
by: I. A. Starodubtseva
Published: (2015-12-01)

Serum calprotectin levels: A measure of disease activity in rheumatoid arthritis
by: Pranshu Dhingra, et al.
Published: (2025-01-01)

The efficiency and safety of tocilizumab in rheumatoid arthritis(intermediate results of a Russian multicenter study)
by: E L Nasonov, et al.
Published: (2010-04-01)

LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)
by: E. L. Nasonov, et al.
Published: (2018-07-01)

Assessment of genetically modified maize DAS1131 (application GMFF‐2021‐1530)
by: EFSA Panel on Genetically Modified Organisms (GMO), et al.
Published: (2025-03-01)

Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up
by: M. M. Kostik, et al.
Published: (2018-01-01)

Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)

Value of ultrasound indices for the assessment of rheumatoid arthritis activity and tocilizumab therapy efficiency
by: Rita Aleksandrovna Osipyants, et al.
Published: (2013-11-01)

CLINICAL CHARACTERISTICS OF THREE COHORTS OF PATIENTS WITH EARLY- AND LATE-ONSET RHEUMATOID ARTHRITIS (AT 50 YEARS OR OLDER). GENERALIZATION OF 40 YEARS’ EXPERIENCE
by: A. M. Satybaldyev, et al.
Published: (2020-04-01)

Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation
by: E. V. Udachkina, et al.
Published: (2015-11-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)